trial · primary record
AP-472
Parkinson Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2028-01-03 |
| Primary endpoint | Change from Baseline in average daily OFF time on motor diaries for AP-472 compared to placebo (normalized to 16-hour awake time) |
| Registry ID | NCT07432958 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:38.540Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07432958
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.